64
Participants
Start Date
August 29, 2025
Primary Completion Date
March 30, 2026
Study Completion Date
April 30, 2026
Dexmedetomidine hydrochloride Microneedles
Randomized in a 1:1 ratio through the randomization system, and assigned to medium-pressure group or low-pressure group.
Dexmedetomidine hydrochloride Microneedles
"In the high weight group, 8 subjects will receive a high dose of Dexmedetomidine hydrochloride Microneedles.~In the high weight group, 8 subjects will receive a low dose of Dexmedetomidine hydrochloride Microneedles."
placebo
In the high weight group, 8 subjects will receive Dexmedetomidine hydrochloride Microneedles blank preparation.
Dexmedetomidine hydrochloride Microneedles
"In the low weight group, 8 subjects will receive a low dose of Dexmedetomidine hydrochloride Microneedles.~In the low weight group, 8 subjects will receive a high dose of Dexmedetomidine hydrochloride Microneedles."
Placebo
In the low weight group, 8 subjects will receive Dexmedetomidine hydrochloride Microneedles blank preparation.
RECRUITING
The First Affiliated Hospital of Jinan University (Guangzhou Overseas Chinese Hospital), Guangzhou
Guangzhou Novaken Pharm Co., Ltd.
INDUSTRY